Medical Writing Patient-reported outcomes Quality of life measures – an overview

Volume 27, Issue 4 - Patient-reported outcomes

Quality of life measures – an overview


HR-QoL measurements attempt to turn subjective information into objective information. In this article, I describe the different kinds of health-related quality of life (HRQoL) measures, how they work, and how they can be interpreted. Main types of HRQoL measures include generic; disease- or population-specific; dimension-specific;individualised; and preference-based. Each serves different purpose and should be applied to different populations. For example, generic measures can be used in general populations and across various diseases, whereas disease-specific ones address specific diseased populations. I also discuss key considerations for using and presenting HR-QoL measures, including ensuring that a validated and legally obtained measure is administered; describing the type and specifics of the HR-QoL measure; and explaining how the measure was used, how
scores were computed, and how to interpret them.

Download the full article


  1. Food and Drug Administration (FDA) already in 2009 published the Guidance for Industry, Patient – Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH); December 2009 [cited 2018 Sep 8]. Available from: Available from: downloads/drugs/guidances/ucm193282. pdf.
  2. Brazier JE, Kolotkin RL, Crosby RD, Williams GR. Estimating a preferencebased single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) Instrument from the SF-6D. Value Health 2004; 7(4):490–8. Available from: http://
  3. Euroqol Group. EuroQoL – a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 19–208. Available from: http://
  4. EQ-5D-3L. 2018 [cited 2018 Sep 8]. Available from: Available from: eq-5d-instruments/eq-5d-3l-about/.
  5. EQ-5D Instruments. 2018 [cited 2018 Aug 12]. Available from: Available from: eq-5d-instruments/ eq-5d-y-availablemodes- of-administration/.
  6. RAND Health 36-Item Short Form Survey (SF-36). 2018 [cited 2018 Aug 13]. Available from: Available from: tools/mos/36-item-short-form.html.
  7. Ellert U, Kurth B-M. [Methodological views on the SF-36 summary scores based on the adult German population]. Bundesgesundheitsblatt. Gesundheitsforschung. Gesundheitsschutz. 2004;47(11):1027–32. Available from: http://
  8. Wiklund I. The Nottingham Health Profile – a measure of health-related quality of life. Scand J Prim Health Care Suppl. 1990;1:15–8. Available from: http://
  9. Bjordal K, Kaasa S. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-Item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol. 1992; 31(3):311–20. Available from: http://
  10. EORTC Quality of life [cited 2018 Sep 13]. Available from: Available from:
  11. EORTC QLQ-C30 Scoring Manual [cited 2018 Sep 13]. Available from: Available from:
  12. Badia X, Webb SM, Prieto L, Lara N. Acromegaly Quality of Life Questionnaire (AcroQoL). Health Qual Life Outcom. 2004;2:13. Available from: http://
  13. Ravens-Sieberer U, Bullinger M. Assessing health related quality of life in chronically ill children with the German KINDL: first psychometric and content-analytical results. Qual Life Res. 1998:7(5): 399–407. Available from: http://
  14. Ravens-Sieberer U, Bullinger M. News from the KINDL-Questionnaire – A new version for adolescents. Qual Life Res. 1999;7:653. Available from: http://
  15. KINDL [cited 2018 Aug 14]. Available from: Available from:
  16. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70. Available from: http://
  17. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1(3):277–99. Available from: http://
  18. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25. Available from: http://
  19. McGee HM, O’Boyle CA, Hickey A, O’Malley K, Joyce CR. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med. 1991;21(3): 749–59. Available from: http://
  20. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient- Generated Index. Med Care. 1994;32(11):1109–26. Available from: http://
  21. O’Boyle C, McGee H, Hickey A, Joyce CRB, Browne J, O’Malley, Hiltbrunner B. The Schedule for the Evaluation of Individual Quality of Life (SEIQoL). Administration Manual. Dublin: Royal College of Surgeons in Ireland; 1993. Available from: http://
  22. Herschbach P, Henrich G, Strasburger CJ, Feldmeir H, Marin F, Attanasio AM, Blum WF. Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. Eur J Endocrinol 2001;145:255–265. Available from: http://
  23. Torrance GW. Utility approach to measuring health-related quality of life. J Chron Dis. 1987;40(6):593–600. Available from: http://
  24. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and diseasespecific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. 2005;60:1571–82. Available from: http://
  25. EQ-5D 5L. Valuation: Standard value sets. [cited 2018 Sep 9]. Available from Available from: eq-5d-5l-about/valuation-standard-valuesets/.
  26. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92. Available from: http://
  27. Patient-reported outcomes (CONSORT PRO) [cited 2018 Sep 9]. Available from Available from: extensions/overview/consort-pro.
  28. The Economist Intelligence Unit’s qualityof- life index. 2005 [cited 2018 Aug 11]. Available from: Available from: QUALITY_OF_LIFE.pdf.
  29. World Health Organization (WHO) 1948 World Health Organization constitution Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19 June – 22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948; Basic Documents, Fortyfifth edition, Supplement. October 2006 [cited 2018 Aug 11]. Available from: Available from: _constitution_en.pdf.
  30. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW, Dix Smith M, editors. Health care, cost, quality and outcomes: ISPOR book of terms. 1st ed. Lawrenceville: International Society for Pharmacoeconomics and Outcomes Research; 2003. Available from: http://
  31. Fayers PM, Machin D. Quality of life, assessment, analysis and interpretation. 1st ed. Chichester, New York, Weinheim, Brisbane, Singapore, Toronto: John Wiley and Sons Ltd; 2001. Available from: http://
  32. Kind P. Methodological issues in the assessment of quality of life. In: Abs R, Feldt-Rasmussen U, editors. Growth Hormone Deficiency in Adults: 10 Years of KIMS. Oxford: Oxford PharmaGenesis; 2004. p. 189–98. Available from: http://
  33. Ware JE, Jr. The status of health assessment. Annu Rev Public Health. 1995;16:327–54. Available from: http://
  34. Wilson IB & Cleary PD. Linking clinical variable with health-related quality of life. JAMA. 1995;273(1):59–65. Available from: http://
  35. Snyder AR, Parsons JT, Valovich McLeod TC, Curtis Bay R, Michener LA, Sauers EL. Using disablement models and clinical outcomes assessment to enable evidencebased athletic training practice, Part I: Disablement Models. J Athl Train. 2008;43(4):428–36. Available from: http://
  36. Calman KC. Quality of life in cancer patients: an hypothesis. J Med Ethics. 1984;10:24–127. Available from: http://
  37. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy. 1992; 22:307–19. Available from: http://
  38. Galen Research, Measures Database [cited 2018 Aug 12]. Available from: Available from:
  39. Kołtowska-Häggström M, Mattsson AF, Shalet SM. Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol. 2009;161:S51-S64. Available from: http://
  40. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham health profile: subjective health status and medical consultations. Soc Sci Med. 1981;15:221–9. Available from: http://
  41. Likert RA. Technique for the measurement of attitudes. Arch Psychol. 1932;140:1–55. Available from: http://
  42. Priestman TJ, Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet. 1976;1(7965):899–900. Available from: http://
  43. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, New York, 2nd ed. Lippincott-Raven Publishers; 1996. Available from: http://



Patient reported outcomes
President's Message
Measuring health outcomes: The foundation of contemporary healthcare decision-making
Measuring quality of life – theoretical background
Quality of life measures – an overview
Publication planning and patient-reported outcomes: Demonstrating value in a multi-stakeholder era
Patient-reported outcome measure translation: An overview
Systematic hospital collection of patient-reported outcome data via patient apps
The PROMIS of electronic patient-reported outcomes
Interview with Professor Matthias Rose on developing patient-reported outcomes and the PROMIS initiative
The UK pharmaceutical industry braces for Brexit, be it mild, severe, or doomsday
Awareness of medical writing as a profession and its career prospects
Estimands – closing the gap between study design and analysis
Protecting the rights of clinical trial patients through disclosure: The significance of plain language
News from the EMA
Regulatory Matters & Regulatory Public Disclosure
Medical Communications
Medical Devices
Journal Watch
In the Bookstores
Good Writing Practice
Getting Your Foot In The Door
My First Medical Writing
Out on Our Own


The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board


Raquel Billiones


Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Brooks Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir


Jennifer Bell


Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer


Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha


Tiziana von Bruchhausen


Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk